M
HUMA icon

Murchinson’s Humacyte HUMA Stock Holding History

Murchinson’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$17.1K – 79
2025
Q1 		$17.1K Buy
+10,000
New +$37.5K ﹤0.01% 98

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Murchinson's HUMA Position: Q2 2025 in Review

Murchinson sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 10,000 shares — an estimated $17.1K sold.

Murchinson first reported a position in HUMA in Q1 2025 and held it in 1 quarter. The position peaked at $17.1K in Q1 2025. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Murchinson reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Murchinson sold 10,000 Humacyte shares in Q2 2025, an estimated $17.1K.
  • Murchinson first reported a position in Humacyte in Q1 2025 and held it in 1 quarter.
  • Murchinson's Humacyte position peaked at $17.1K in Q1 2025.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Murchinson's 13F filing for Q2 2025, filed 14 Aug 2025.